{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:07:18Z","timestamp":1782950838991,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.7759\/cureus.34528","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T07:49:59Z","timestamp":1675324199000},"source":"Crossref","is-referenced-by-count":1,"title":["Synovium to Myocardium: A Case of Calcium Pyrophosphate Dihydrate Crystal Arthritis Associated With Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"Mahanoor","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masooma S","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobeena","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofeek","family":"Akinpelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1511117","article-title":"Calcium pyrophosphate deposition disease","volume":"374","author":"Rosenthal AK","year":"2016","unstructured":"Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016, 374:2575-84. 10.1056\/NEJMra1511117","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5 A","year":"2017","unstructured":"Gister\u00e5 A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017, 13:368-80. 10.1038\/nrneph.2017.51","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.01.005","article-title":"Comorbidities in patients with crystal diseases and hyperuricemia","volume":"40","author":"Sattui SE","year":"2014","unstructured":"Sattui SE, Singh JA, Gaffo AL. Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am. 2014, 40:251-78. 10.1016\/j.rdc.2014.01.005","journal-title":"Rheum Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01081-5","article-title":"Cardiovascular disease in gout and the\u00a0protective effect of treatments including urate-lowering therapy","volume":"79","author":"Gupta MK","year":"2019","unstructured":"Gupta MK, Singh JA. Cardiovascular disease in gout and the\u00a0protective effect of treatments including urate-lowering therapy. Drugs. 2019, 79:531-41. 10.1007\/s40265-019-01081-5","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06101-6","article-title":"Outcomes and resource utilization in calcium pyrophosphate deposition disease patients who underwent total knee arthroplasty: a cross-sectional analysis","volume":"41","author":"Parperis K","year":"2022","unstructured":"Parperis K, Hadi M, Bhattarai B. Outcomes and resource utilization in calcium pyrophosphate deposition disease patients who underwent total knee arthroplasty: a cross-sectional analysis. Clin Rheumatol. 2022, 41:1817-24. 10.1007\/s10067-022-06101-6","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24783","article-title":"Cardiovascular disease risk in calcium pyrophosphate deposition disease: a nationwide study of veterans","author":"Bashir M","year":"2021","unstructured":"Bashir M, Sherman KA, Solomon DH, Rosenthal A, Tedeschi SK. Cardiovascular disease risk in calcium pyrophosphate deposition disease: a nationwide study of veterans. Arthritis Care Res (Hoboken). 2021, 10.1002\/acr.24783","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","article-title":"Acute coronary syndrome in calcium pyrophosphate deposition disease patients: a cross-sectional study from the national inpatient sample","volume":"74","author":"Parperis K","year":"2022","unstructured":"Parperis K, Bhattarai B. Acute coronary syndrome in calcium pyrophosphate deposition disease patients: a cross-sectional study from the national inpatient sample. Arthritis Rheumatol. 2022, 74:1817.","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1916","article-title":"An unusual case of acute chondrocalcinosis in wrist joint presenting as cellulitis","volume":"9","author":"Awan R","year":"2017","unstructured":"Awan R, Ghazanfar H, Martes Pena KA, Farkhad RI. An unusual case of acute chondrocalcinosis in wrist joint presenting as cellulitis. Cureus. 2017, 9:e1916. 10.7759\/cureus.1916","journal-title":"Cureus"},{"key":"ref9","article-title":"Calcium pyrophosphate deposition disease in the ankle joint: a case report","volume":"61","author":"Stainsby BE","year":"2017","unstructured":"Stainsby BE, Ellul N, Dimopoulos A, Lubberdink C, Salerno V, Solomon M. Calcium pyrophosphate deposition disease in the ankle joint: a case report. J Can Chiropr Assoc. 2017, 61:40-4.","journal-title":"J Can Chiropr Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.21585","article-title":"Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms","volume":"53","author":"Pego-Reigosa JM","year":"2005","unstructured":"Pego-Reigosa JM, Rodriguez-Rodriguez M, Hurtado-Hernandez Z, et al.. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Arthritis Rheum. 2005, 53:931-8. 10.1002\/art.21585","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S29284","article-title":"Erythrocyte sedimentation rate as a marker for coronary heart disease","volume":"8","author":"Yayan J","year":"2012","unstructured":"Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag. 2012, 8:219-23. 10.2147\/VHRM.S29284","journal-title":"Vasc Health Risk Manag"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes243","article-title":"Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis","volume":"52","author":"Liao KP","year":"2013","unstructured":"Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford). 2013, 52:45-52. 10.1093\/rheumatology\/kes243","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie A","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, et al.. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015, 74:326-32. 10.1136\/annrheumdis-2014-205675","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205252","article-title":"Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink","volume":"74","author":"Clarson LE","year":"2015","unstructured":"Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015, 74:642-7. 10.1136\/annrheumdis-2014-205252","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen J","year":"2017","unstructured":"Chen J, Budoff MJ, Reilly MP, et al.. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017, 2:635-43. 10.1001\/jamacardio.2017.0363","journal-title":"JAMA Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203400","article-title":"Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study","volume":"73","author":"Abhishek A","year":"2014","unstructured":"Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M. Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study. Ann Rheum Dis. 2014, 73:1997-2002. 10.1136\/annrheumdis-2013-203400","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163879","article-title":"Inflammation and cardiovascular diseases: the most recent findings","volume":"20","author":"Sorriento D","year":"2019","unstructured":"Sorriento D, Iaccarino G. Inflammation and cardiovascular diseases: the most recent findings. Int J Mol Sci. 2019, 20:3879. 10.3390\/ijms20163879","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani SS","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al.. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021, 143:e254-743. 10.1161\/CIR.0000000000000950","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-020-00459-1","article-title":"Gout pharmacotherapy in cardiovascular diseases: a review of utility and outcomes","volume":"21","author":"Kaul S","year":"2021","unstructured":"Kaul S, Gupta M, Bandyopadhyay D, et al.. Gout pharmacotherapy in cardiovascular diseases: a review of utility and outcomes. Am J Cardiovasc Drugs. 2021, 21:499-512. 10.1007\/s40256-020-00459-1","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos SG","year":"2022","unstructured":"Deftereos SG, Beerkens FJ, Shah B, et al.. Colchicine in cardiovascular disease: in-depth review. Circulation. 2022, 145:61-78. 10.1161\/CIRCULATIONAHA.121.056171","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/94014-synovium-to-myocardium-a-case-of-calcium-pyrophosphate-dihydrate-crystal-arthritis-associated-with-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:14Z","timestamp":1707508214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/94014-synovium-to-myocardium-a-case-of-calcium-pyrophosphate-dihydrate-crystal-arthritis-associated-with-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.34528","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}